Literature DB >> 17491538

Factors affecting the outcome of methadone maintenance treatment in opiate dependence.

F Kamal1, S Flavin, F Campbell, C Behan, J Fagan, R Smyth.   

Abstract

This study aimed to measure the rates of ongoing heroin abuse among patients on methadone maintenance treatment (MMT) and sought to identify patient and treatment characteristics associated with poorer outcome. The study was carried out at an outpatient drug treatment clinic and included all patients who were on the MMT during a three month period in 2004. Treatment response was measured from analysis of opiate positive urine samples. Of the 440 patients, 63% were male and their mean age was 32 years (range 17 to 52 years). 163 patients (37%) had a comorbid psychiatric illness. The average methadone dose was 74 mg. On average, 71% of urine samples were opiate negative. Shorter time in treatment (less than 24 months), lower dose of methadone, cocaine abuse and intermittent benzodiazepine abuse were each found to be significantly associated with lower rates of opiate abstinence. Outcomes were not associated with gender, age and accessing counselling. Dual diagnosed patients tended to have higher rates of abstinence (p = 0.08). MMT clients who abuse cocaine and benzodiazepines are at increased risk of continuing opiate abuse. Higher doses of methadone might be necessary to prevent illicit opiate abuse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17491538

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  22 in total

1.  Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Authors:  Aishwarya Vijay; Alexander R Bazazi; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2015-02-18

Review 2.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

3.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

4.  Concurrent heroin use among methadone maintenance clients in China.

Authors:  Li Li; Chunqing Lin; Dai Wan; Linglin Zhang; Wenhong Lai
Journal:  Addict Behav       Date:  2011-11-07       Impact factor: 3.913

5.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

6.  Sex effects in cocaine-using methadone patients randomized to contingency management interventions.

Authors:  Ashley E Burch; Carla J Rash; Nancy M Petry
Journal:  Exp Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.157

7.  The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Authors:  Eugenia Oviedo-Joekes; Bohdan Nosyk; Suzanne Brissette; Jill Chettiar; Pascal Schneeberger; David C Marsh; Michael Krausz; Aslam Anis; Martin T Schechter
Journal:  J Urban Health       Date:  2008-08-29       Impact factor: 3.671

8.  Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.

Authors:  Iuliia Makarenko; Alyona Mazhnaya; Ruthanne Marcus; Iryna Pykalo; Lynn Madden; Sergii Filippovich; Sergii Dvoriak; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2018-01-11

9.  Benzodiazepine use and misuse among patients in a methadone program.

Authors:  Kevin W Chen; Christine C Berger; Darlene P Forde; Christopher D'Adamo; Eric Weintraub; Devang Gandhi
Journal:  BMC Psychiatry       Date:  2011-05-19       Impact factor: 3.630

10.  Clinical Efficacy of Traditional Chinese Medicine, Suan Zao Ren Tang, for Sleep Disturbance during Methadone Maintenance: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Yuan-Yu Chan; Yi-Hung Chen; Szu-Nian Yang; Wan-Yu Lo; Jaung-Geng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.